Original Research
Accepted on 06 Oct 2025
Comparative Cardiovascular Risks of Canagliflozin and selective SGLT2 Inhibitors in Type 2 Diabetes
in Cardiovascular and Smooth Muscle Pharmacology
- 113 views
Original Research
Accepted on 06 Oct 2025
in Cardiovascular and Smooth Muscle Pharmacology
Case Report
Accepted on 06 Oct 2025
in Gastroenterology
Original Research
Accepted on 06 Oct 2025
in Genetics of Common and Rare Diseases
Original Research
Accepted on 06 Oct 2025
in Genitourinary Surgery and Interventions
Original Research
Accepted on 06 Oct 2025
in Predictive Toxicology
Original Research
Accepted on 06 Oct 2025
in Public Health Education and Promotion
Original Research
Accepted on 06 Oct 2025
in Human-Media Interaction
Original Research
Accepted on 06 Oct 2025
in Neuropharmacology
Systematic Review
Accepted on 06 Oct 2025
in Neuropharmacology
Original Research
Accepted on 06 Oct 2025
in Obstetrics and Gynecology
Original Research
Accepted on 06 Oct 2025
in Plant Metabolism and Chemodiversity
Original Research
Accepted on 06 Oct 2025
in Radiation Detectors and Imaging
Original Research
Accepted on 06 Oct 2025
in Leadership in Education
Original Research
Accepted on 06 Oct 2025
in Intensive Care Medicine and Anesthesiology
Systematic Review
Accepted on 06 Oct 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 06 Oct 2025
in Transplantation Immunology